Drug intelligence / Profile preview

Accordion Pill Zaleplon (Intec Pharma Ltd.)

Development stage
Unknown
Lead developer
Indaptus Therapeutics
Modality
Small Molecules
Administration
Oral
01

Overview

Accordion Pill Zaleplon (AP-ZP) is a gastroretentive, controlled-release formulation of the non-benzodiazepine hypnotic zaleplon, developed by Intec Pharma for the treatment of insomnia. The formulation utilizes Intec's proprietary Accordion Pill technology, which consists of a multi-layer, biodegradable film folded into a standard-size capsule. Upon reaching the stomach, the capsule dissolves, and the film unfolds, allowing it to be retained in the stomach for several hours. This gastroretention enables the controlled release of zaleplon into the upper gastrointestinal tract, extending its absorption window. The goal of this delivery system is to leverage zaleplon's short half-life to provide effective sleep maintenance throughout the night while ensuring that drug levels drop sufficiently by morning to avoid next-day residual effects or sedation.

Brand names
Accordion Pill Zaleplon
Other names
AP-ZPIN 10 003IN10 003IN-10 003Accordion Pill-Zaleplon
02

Targets

BZD site (GABA-A receptor benzodiazepine site)GABRA1 (Gamma-aminobutyric acid type A receptor alpha 1 subunit)

Beyond the preview

Go deeper on Accordion Pill Zaleplon (Intec Pharma Ltd.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Accordion Pill Zaleplon (Intec Pharma Ltd.).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call